Loading company…
PetDx provides a blood-based early cancer detection test for dogs.
Founded in 2019 and based in La Jolla, US, PetDx develops molecular diagnostics for early cancer detection in dogs. Its OncoK9 test uses a blood sample, genomic analysis and sequencing to identify cancer-related changes for veterinary review. In December 2021, the company raised USD 62 million in Series B funding led by Longview Asset Management, with participation from Aperture Venture Partners and Declaration Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in